Characterization of MET exon 14 skipping alterations (METex14) in non–small cell lung cancer (NSCLC) using whole transcriptome sequencing (WTS).

Authors

null

So Yeon Kim

Montefiore Medical Center, Bronx, NY

So Yeon Kim , Stephen Bohlman , Jun Yin , Haiying Cheng , Phillip Walker , Sanja Dacic , Chul Kim , Hina Khan , Stephen V. Liu , Patrick C. Ma , Misako Nagasaka , Karen L. Reckamp , Jim Abraham , Dipesh Uprety , Balazs Halmos

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 9122)

DOI

10.1200/JCO.2022.40.16_suppl.9122

Abstract #

9122

Poster Bd #

108

Abstract Disclosures

Similar Posters

First Author: Jennifer Aline Marks

First Author: Jennifer Aline Marks

Poster

2018 ASCO Annual Meeting

Concurrent genomic alterations in lung adenocarcinoma with a <em>MET</em> exon 14 skipping mutation.

Concurrent genomic alterations in lung adenocarcinoma with a MET exon 14 skipping mutation.

First Author: Julia Rotow